Abstract

Mortality was higher for patients treated with DCLHb. Although further analysis should investigate whether the mortality difference was solely due to a direct treatment effect or to other factors, DCLHb does not appear to be an effective resuscitation fluid.

Keywords

MedicineResuscitationAnesthesiaShock (circulatory)SalineRandomized controlled trialSurgeryInternal medicine

MeSH Terms

AdultAspirinBlood SubstitutesFemaleFluid TherapyHemoglobinsHumansLogistic ModelsMaleMiddle AgedMultiple Organ FailureShockHemorrhagicSingle-Blind MethodSodium ChlorideStatisticsNonparametricSurvival AnalysisTrauma Severity Indices

Affiliated Institutions

Related Publications

Publication Info

Year
1999
Type
article
Volume
282
Issue
19
Pages
1857-1857
Citations
467
Access
Closed

Citation Metrics

467
OpenAlex
2
Influential
400
CrossRef

Cite This

Edward P. Sloan, Max Koenigsberg, David Gen�s et al. (1999). Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic Shock<SUBTITLE>A Randomized Controlled Efficacy Trial</SUBTITLE>. JAMA , 282 (19) , 1857-1857. https://doi.org/10.1001/jama.282.19.1857

Identifiers

DOI
10.1001/jama.282.19.1857
PMID
10573278

Data Quality

Data completeness: 86%